Saturday 17 October 2026 Export COLL’s income statement to Excel — free account

Collegium Pharmaceutical, Inc.

COLL Healthcare Drug Manufacturers Specialty & Generic

Collegium Pharmaceutical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $780.6 million, up 23.6% from fiscal 2024. In the quarter to June 2026, revenue grew 6.32%, EPS fell 221.1%, free cash flow fell 2.14% and total debt rose 32.6%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

23.19 0.01 +0.04%

Follow COLL

Alert me

Market cap: $754.6M
P/E: 15.2×
Fwd P/E: 12.5×
Dividend yield: —
F-score: 7/9
Altman Z: 1.58
Beneish M: −3.32
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	17.61%	27.41%	23.70%	22.96%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	6	9	7	7
ROA Full definition →	2.57%	4.57%	3.79%	3.60%
ROIC Full definition →	7.85%	17.52%	15.94%	12.62%
Return on Tangible Assets Full definition →	166.34%	23.25%	23.87%	33.75%
Average Days of Receivables Full definition →	128.76	104.85	98.82	112.79
Free Cash Flow per Share Full definition →	10.11	10.28	10.33	9.16
Free Cash Flow Full definition →	328.28	329.83	327.58	289.30
Capital Expenditures Full definition →	(1.64)	(1.21)	(1.74)	(1.62)
Other line items
Cash ROIC Full definition →	21.14%	21.19%	21.59%	20.83%
Accounts Receivable Turnover Full definition →	3.25	3.48	3.55	3.27
Accounts Payable Turnover Full definition →	32.10	25.38	43.49	60.04
Inventory Turnover Full definition →	4.27	7.83	8.30	8.51
Average Days of Payables Full definition →	10.44	7.96	12.26	8.62
Days of Inventory on Hand Full definition →	127.95	49.82	47.06	42.88
Tax Rate Full definition →	(0.38)	(0.31)	(0.32)	(0.28)
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	40.54%	37.01%	36.49%	37.02%
Share Based Compensation of Revenue Full definition →	5.56%	5.18%	5.37%	5.25%
Interest Coverage Full definition →	2.06	2.44	2.18	1.83
Operating CF/Net income Full definition →	6.89	4.42	5.24	4.98
Depreciation/Fixed assets Full definition →	21.86	19.25	18.73	18.37
Capex/Depreciation Full definition →	(0.01)	(0.01)	(0.01)	(0.01)
Revenue per Share Full definition →	24.90	24.82	24.62	23.98
Operating CF per Share Full definition →	10.16	10.32	10.39	9.21
Capex per Share Full definition →	(0.05)	(0.04)	(0.05)	(0.05)
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly